USD10
KROS Shares
About Keros TherapeuticsKeros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
USD10
KROS Shares
About Keros TherapeuticsKeros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$211.77M
OPEN PRICE
$10.58
LOW (1Y)
$9.69
HIGH (1Y)
$22.55
LOW (24H)
$10.37
HIGH (24H)
$10.76
VOLUME (24H)
$142.83K
43.23%
Price history
Time | Price | Change |
|---|---|---|
Today | $10.58 | |
1 Day | $10.47 | |
1 Week | $11.57 | |
1 Month | $10.67 | |
1 Year | $13.79 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.